Kingskin

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, “cauliflower-like” surface appearance.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedure for the application of the treatment to ensure optimal results.

The affected area should be washed thoroughly and dried completely before application. Using the provided applicator, one drop of the treatment should be applied at a time to ensure sufficient coverage of each wart. After application, the area should be allowed to dry.

This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to irritated skin, infected areas, or any regions exhibiting redness. It is contraindicated in individuals with diabetes or poor blood circulation due to the potential for adverse effects. Application is also prohibited on moles, birthmarks, warts with hair, genital warts, or warts located on the face. Additionally, the product must not be used on mucous membranes.

For safety, this product is for external use only and is flammable; it should be kept away from fire or flame.

Warnings and Precautions

For external use only. This product is flammable; it must be kept away from fire or flame. It is contraindicated for use on irritated skin or any area that is infected or reddened. Individuals with diabetes or poor blood circulation should not use this product. Additionally, it should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face. The product is also not intended for use on mucous membranes.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

General precautions include ensuring that the bottle is tightly capped when not in use. If the product comes into contact with the eyes, it is essential to flush the eyes with water for at least 15 minutes. Patients should also be cautioned to avoid inhaling vapors associated with the product.

Side Effects

Patients should be aware of the following warnings and precautions associated with the use of this product. It is contraindicated for use on irritated skin, any area that is infected or reddened, and should not be applied if the patient is diabetic or has poor blood circulation. Additionally, the product should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face, nor should it be applied to mucous membranes.

During the use of this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Patients are also advised to avoid inhaling vapors from the product.

Patients should discontinue use and consult a healthcare professional if discomfort persists. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Drug Interactions

There are no specific drug interactions identified in the available data. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Kingskin (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center for guidance.

Geriatric Use

There is no specific information regarding the use of KINGSKIN (salicylic acid liquid) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for adverse effects may be prudent in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of Kingskin (salicylic acid) during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for this population. Given the lack of information, healthcare professionals should exercise caution when considering the use of Kingskin in women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to discuss alternative treatment options with pregnant patients or those planning to become pregnant.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of information may necessitate careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential risks associated with overdosage.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential for appropriate management.

Management procedures may include supportive care and symptomatic treatment, tailored to the specific symptoms presented by the patient. Continuous monitoring of vital signs and clinical status is recommended to ensure patient safety and effective intervention.

In all cases of suspected overdosage, timely communication with poison control and adherence to established treatment protocols are vital for optimal patient outcomes.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that the product is for external use only and is flammable; therefore, it should be kept away from fire or flame. Patients must be informed not to use the product on irritated skin, infected areas, or any reddened skin. It is crucial to emphasize that individuals with diabetes or poor blood circulation should not use this product.

Patients should also be cautioned against using the product on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face. Additionally, the product should not be applied to mucous membranes.

Healthcare providers should instruct patients to stop using the product and consult a doctor if discomfort persists. When using the product, patients should ensure that the bottle is capped tightly after each use. In the event that the product comes into contact with the eyes, patients should flush the eyes with water for 15 minutes. Lastly, patients should be advised to avoid inhaling vapors associated with the product.

In case of accidental ingestion, patients must seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in packaging that includes an NDC number for identification. It should be stored at room temperature, away from heat sources, to maintain its integrity. Healthcare professionals are advised to inspect the product prior to use; it should not be used if the seal over the cap is torn or missing, as this may compromise the product's safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Kingskin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)